KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The study aimed to search and identify genes that were differentially expressed in breast cancer, and their roles in cancer growth and progression. Materials and Methods The Gene Expression Omnibus (Oncomine) and The Cancer Genome Atlas databases (https://cancergenome.nih.gov/) were screened for genes that were expressed differentially in breast cancer and were closely related to a poor prognosis. Gene expressions were verified by quantitative real-time polymerase chain reaction, and genes were knocked down by a lentivirus-based system. Cell growth and motility were evaluated and in vivo nude mice were used to confirm the in vitro roles of genes. Markers of epithelial-to-mesenchymal transition and the associations of KIF11 with the classical cancer signaling pathways were detected by Western blot. Results A series of genes expressed differentially in patients with breast cancer. The prognosis associated with high KIF11 expression was poor, and the expression of KIF11 increased significantly in high stage and malignant tumor cells. Inhibiting KIF11 expression in lentivirussuppressed cells revealed that KIF11 inhibition significantly reduced cell viability and colony formation, inhibited migration and invasion, but promoted apoptosis. The sizes and weights of KIF11-inhibited tumors in nude mice were significantly lower than in the negative controls. Western blot showed that E-cadherin in breast cancer was significantly upregulated in KIFinhibited cells and tumor tissues, whereas N-cadherin and vimentin were significantly downregulated. BT549 and MDA231 cells with KIF11 knockdown exhibited decreased ERK, AMPK, AKT, and CREB phosphorylation. Conclusion KIF11 acts as a potential oncogene that regulates the development and progression of breast cancer.
Abstract
Purpose The study aimed to search and identify genes that were differentially expressed in breast cancer, and their roles in cancer growth and progression. Materials and Methods The Gene Expression Omnibus (Oncomine) and The Cancer Genome Atlas databases (https://cancergenome.nih.gov/) were screened for genes that were expressed differentially in breast cancer and were closely related to a poor prognosis. Gene expressions were verified by quantitative real-time polymerase chain reaction, and genes were knocked down by a lentivirus-based system. Cell growth and motility were evaluated and in vivo nude mice were used to confirm the in vitro roles of genes. Markers of epithelial-to-mesenchymal transition and the associations of KIF11 with the classical cancer signaling pathways were detected by Western blot. Results A series of genes expressed differentially in patients with breast cancer. The prognosis associated with high KIF11 expression was poor, and the expression of KIF11 increased significantly in high stage and malignant tumor cells. Inhibiting KIF11 expression in lentivirussuppressed cells revealed that KIF11 inhibition significantly reduced cell viability and colony formation, inhibited migration and invasion, but promoted apoptosis. The sizes and weights of KIF11-inhibited tumors in nude mice were significantly lower than in the negative controls. Western blot showed that E-cadherin in breast cancer was significantly upregulated in KIFinhibited cells and tumor tissues, whereas N-cadherin and vimentin were significantly downregulated. BT549 and MDA231 cells with KIF11 knockdown exhibited decreased ERK, AMPK, AKT, and CREB phosphorylation. Conclusion KIF11 acts as a potential oncogene that regulates the development and progression of breast cancer.
참고문헌 (37)
- Zuo TT, "Female breast cancer incidence and mortality in China, 2013", Thorac Cancer, 8, pp.214~218 (2017)
- Chen W, "Cancer statistics in China, 2015", CA Cancer J Clin, 66, pp.115~132 (2016)
- DeSantis CE, "Breast cancer statistics, 2017, racial disparity in mortality by state", CA Cancer J Clin, 67, pp.439~448 (2017)
- Mishra P, "ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming", J Clin Invest, 128, pp.323~340 (2018)
- Chen Y, "The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer", J Biol Chem, 283, pp.17969~17978 (2008)
- Traub F, "Prognostic impact of Skp2 and p27 in human breast cancer", Breast Cancer Res Treat, 99, pp.185~191 (2006)
- Marcotte R, "Functional genomic landscape of human breast cancer drivers, vulnerabilities, and resistance", Cell, 164, pp.293~309 (2016)
- Boehm JS, "Integrative genomic approaches identify IKBKE as a breast cancer oncogene", Cell, 129, pp.1065~1079 (2007)
- Rhodes DR, "Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles", Neoplasia, 9, pp.166~180 (2007)
- Roostalu J, "Directional switching of the kinesin Cin8 through motor coupling", Science, 332, pp.94~99 (2011)
- Ma HT, "Synergism between inhibitors of Aurora A and KIF11 overcomes KIF15-dependent drug resistance", Mol Oncol, 8, pp.1404~1418 (2014)
- Hu H, "KIF11 mutations are a common cause of autosomal dominant familial exudative vitreoretinopathy", Br J Ophthalmol, 100, pp.278~283 (2016)
- Rao FQ, "Mutations in LRP5,FZD4, TSPAN12, NDP, ZNF408, or KIF11genes account for 38.7% of Chinese patients with familial exudative vitreoretinopathy", Invest Ophthalmol Vis Sci, 58, pp.2623~2629 (2017)
- Mears K, "Autosomal dominant microcephaly associated with congenital lymphedema and chorioretinopathy due to a novel mutation in KIF11", JAMA Ophthalmol, 133, pp.720~721 (2015)
- Hu C, "PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population", PLoS One, 4, pp.e7643~ (2009)
- Imai T, "Overexpression of KIF11 in gastric cancer with intestinal mucin phenotype", Pathobiology, 84, pp.16~24 (2017)
- Wissing MD, "Nuclear Eg5(kinesin spindle protein)expression predicts docetaxel response and prostate cancer aggressiveness", Oncotarget, 5, pp.7357~7367 (2014)
- Sun D, "The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma", Med Oncol, 30, pp.476~ (2013)
- Liu L, "Overexpression of Eg5 correlates with high grade astrocytic neoplasm", J Neurooncol, 126, pp.77~80 (2016)
- Lu M, "The prognostic role of Eg5 expression in laryngeal squamous cell carcinoma", Pathology, 48, pp.214~218 (2016)
- Daigo K, "Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer", Int J Oncol, 52, pp.155~165 (2018)
- Liu M, "Ectopic expression of the microtubule-dependent motor protein Eg5promotes pancreatic tumourigenesis", J Pathol, 221, pp.221~228 (2010)
- Venere M, "The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma", Sci Transl Med, 7, pp.304~ (2015)[DOI]
- Sun XD, "Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5", Acta Pharmacol Sin, 32, pp.1543~1548 (2011)
- Planas-Silva MD, "Estrogen-dependent regulation of Eg5 in breast cancer cells", Anticancer Drugs, 18, pp.773~779 (2007)
- Guido BC, "Impact of kinesin Eg5 inhibition by 3, 4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features", BMC Cancer, 15, pp.283~ (2015)
- De Iuliis F, "The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells", Invest New Drugs, 34, pp.399~406 (2016)
- Creighton CJ, "Epithelial-mesenchymal transition(EMT)in tumor-initiating cells and its clinical implications in breast cancer", J Mammary Gland Biol Neoplasia, 15, pp.253~260 (2010)
- Taglieri L, "The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells", Invest New Drugs, 36, pp.28~35 (2018)
- Wang TL, "Prevalence of somatic alterations in the colorectal cancer cell genome", Proc Natl Acad Sci U S A, 99, pp.3076~3080 (2002)
- Weng AP, "Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia", Science, 306, pp.269~271 (2004)
- Armstrong L, "The role of PI3K", AKT, MAPK, Hum Mol Genet, pp.2006, 15[DOI]
- Huang B, "PKCepsilon inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K", Akt, MAPK, Cancer Lett, pp.2016, 376[DOI]
- Hu X, "FAT1 prevents epithelial mesenchymal transition(EMT)via MAPK", ERK signaling pathway in esophageal squamous cell cancer, 2017, pp.397, 83~93
- Kim D, "Akt", PKB promotes cancer cell invasion via increased motility and metalloproteinase production, 2001, pp.15, 1953~1962
- Chang F, "Involvement of PI3K", Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation : a target for cancer chemotherapy, 2003, pp.17, 590~603
- Jacinto E, "SIN1", MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity, 2006, pp.127, 125~137